Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for ASCT in Patients with Low- or Intermediate-Risk AML

Shulian Chen, Xiaoyu Zhang, Yi He, Sizhou Feng, Mingzhe Han, Xingli Zhao, Jie Bai, Lijuan Li, Zhihua Zhang, Wang Ying, Jianxiang Wang, Weihua Zhai, Erlie Jiang

Blood (2024) 144 (Supplement 1): 6054.

https://doi.org/10.1182/blood-2024-202404

Published: 2024

Journal Articles

Allogeneic Peripheral Blood Stem Cell Transplantation for Myeloid Sarcoma: A Single-Center Experience

Dewan Zhao, Wenbin Cao, Gang Li, Ying Zhang, Xiaohui Zheng, Xin Chen, Weihua Zhai, Qiaoling MA, Rongli Zhang, Jialin Wei, Aiming Pang, Yi He, Donglin Yang, Sizhou Feng, Mingzhe Han, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7432.

https://doi.org/10.1182/blood-2024-205145

Published: 2024

Journal Articles

Humanized Anti-CD25 Monoclonal Antibody for Graft-Versus-Host Disease Prophylaxis in Older Patients Receiving Haploidentical Hematopoietic Stem Cell Transplantation

Xiaoyu Zhang, Weihua Zhai, Qiaoling MA, Sizhou Feng, Yi He, Mingzhe Han, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7366.

https://doi.org/10.1182/blood-2024-207353

Published: 2024

Journal Articles

The Efficacy and Safety of the Addition of Mitoxantrone Hydrochloride Liposome in Conditioning Regimen for High-Risk Acute Myeloid Leukemia: The Short-TERM Analysis

Xiaoyu Zhang, Weihua Zhai, Qiaoling MA, Mingzhe Han, Sizhou Feng, Yi He, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7318.

https://doi.org/10.1182/blood-2024-207762

Published: 2024

Journal Articles

The Comparison between Chimeric Mouse-Human and Humanized Anti-CD25 Monoclonal Antibody for Steroid-Refractory Acute Graft-Versus-Host Disease

Xinhui Zheng, Xin Chen, Yawei Zheng, Weihua Zhai, Donglin Yang, Jialin Wei, Aiming Pang, Mingzhe Han, Erlie Jiang

Blood (2024) 144 (Supplement 1): 2144.

https://doi.org/10.1182/blood-2024-207001

Published: 2024

Journal Articles

Outcomes of Hematopoietic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for B-Cell Acute Lymphoblastic Leukemia without VOD/SOS

Erlie Jiang, Mengnan Lv, Weihua Zhai

Blood (2024) 144 (Supplement 1): 5855.

https://doi.org/10.1182/blood-2024-204523

Published: 2024

Journal Articles

The Modified Melphalan-Cladribine-Busulfan-Cyclophosphamide (MCBC) Conditioning Regimen Improved Relapse-Free Survival after Allo-HSCT in Refractory/Relapsed AML

Xiaoyu Zhang, Shulian Chen, Weihua Zhai, Yi He, Sizhou Feng, Mingzhe Han, Ting Niu, Yajing Xu, Guangxun Gao, Shengjin Fan, Zepin Zhou, Fang Zhou, Rui Xi, Li Liu, Wei Yang, Xi Zhang, Qifa Liu, Erlie Jiang

Blood (2023) 142 (Supplement 1): 474.

https://doi.org/10.1182/blood-2023-184477

Published: 2023

Journal Articles

Venetoclax Plus Azacitidine Versus Azacitidine Alone As Post-Transplant Maintenance Treatment in High-Risk AML and MDS

Yigeng Cao, Wenwen Guo, Weihua Zhai, Jialin Wei, Qiaoling MA, Donglin Yang, AiMing Pang, Mingzhe Han, Erlie Jiang

Blood (2023) 142 (Supplement 1): 4952.

https://doi.org/10.1182/blood-2023-180847

Published: 2023

Journal Articles

A Modified Busulfan/Cyclophosphamide Preconditioning Regimen Incorporating Selinexor for Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hematologic Malignancies

Xiaofei Ni, Weihua Zhai, AiMing Pang, Donglin Yang, Xin Chen, Qiaoling MA, Jialin Wei, Yi He, Sizhou Feng, Mingzhe Han, Rongli Zhang, Erlie Jiang

Blood (2023) 142 (Supplement 1): 6974.

https://doi.org/10.1182/blood-2023-181449

Published: 2023

Journal Articles

Ceftazidime-Avibactam in the Treatment of Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacteria in Hematological Patients: Experience in a Single Center

Sisi Zhen, Qingsong Lin, Weihua Zhai, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 5363.

https://doi.org/10.1182/blood-2023-188815

Published: 2023

Journal Articles

The Efficacy and Safety of the Third Generation TKI Olverembatinib in Adult Ph+ Acute Lymphoblastic Leukemia with Relapsed Disease or Persistent MRD Bridging to Allo-HSCT: A Case Series from a Single Center

Xiaoyu Zhang, Yanhong Zhao, Rongli Zhang, Weihua Zhai, Yi He, Jialin Wei, Donglin Yang, Aiming Pang, Qiaoling MA, Xin Chen, Mingzhe Han, Sizhou Feng, Erlie Jiang

Blood (2023) 142 (Supplement 1): 5892.

https://doi.org/10.1182/blood-2023-184400

Published: 2023

Journal Articles

Efficacy and Safety of Olverembatinib-Based Therapies in Patients with Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia

Yanhong Zhao, Weihua Zhai, Aiming Pang, Donglin Yang, Yi He, Jialin Wei, Qiaoling MA, Xin Chen, Mingzhe Han, Sizhou Feng, Rongli Zhang, Erlie Jiang

Blood (2023) 142 (Supplement 1): 5893.

https://doi.org/10.1182/blood-2023-184565

Published: 2023

Journal Articles

The Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for Autologous-HSCT in Low-Risk and Intermediate-Risk AML Patients

Weihua Zhai, Shulian Chen, Xiaoyu Zhang, Yi He, Sizhou Feng, Mingzhe Han, Xingli Zhao, Jie Bai, Lijuan Li, Zhihua Zhang, Ying Wang, Erlie Jiang, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 7073.

https://doi.org/10.1182/blood-2023-180077

Published: 2023

Journal Articles

Inotuzumab Ozogamicin in Lymphoid B Cell Malignancy：a Single Center Analysis in the Real World

Mengnan Lv, Yi He, Donglin Yang, Qiaoling MA, Aiming Pang, Weihua Zhai, Jialin Wei, Xin Chen, Sizhou Feng, Mingzhe Han, Rongli Zhang, Erlie Jiang

Blood (2023) 142 (Supplement 1): 5900.

https://doi.org/10.1182/blood-2023-188534

Published: 2023

Journal Articles

A Real-World Efficacy of Letermovir Primary Prophylaxis for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation in China: A Single-Center Retrospective Analysis

Xiaoyu Zhang, Donglin Yang, Aiming Pang, Yi He, Jialin Wei, Rongli Zhang, Weihua Zhai, Qiaoling MA, Xin Chen, Mingzhe Han, Sizhou Feng, Erlie Jiang

Blood (2023) 142 (Supplement 1): 7027.

https://doi.org/10.1182/blood-2023-182816

Published: 2023

Journal Articles

The Efficacy and Safety of Modified Melphalan and Busulfan-Based Conditioning Regimen for Allogeneic-HSCT in Refractory/Relapsed or Persistent MRD Positive AML Patients

Shulian Chen, Xiaoyu Zhang, Weihua Zhai, Yi He, Sizhou Feng, Mingzhe Han, Ting Niu, Yajing Xu, Guangxun Gao, Shengjin Fan, Zeping Zhou, Fang Zhou, Xi Rui, Li Liu, Wei Yang, Qifa Liu, Xi Zhang, Erlie Jiang

Blood (2022) 140 (Supplement 1): 10467–10468.

https://doi.org/10.1182/blood-2022-165140

Published: 2022

Journal Articles

Combination of Cytogenetic Classification and MRD Status Correlates with Outcomes of Autologous Versus Allogeneic Stem Cell Transplantation in Adults with B Cell-Acute Lymphoblastic Leukemia in First Remission

Rongli Zhang, Mengnan Lyu, Yi He, Donglin Yang, Aiming Pang, Jialin Wei, Qiaoling Ma, Weihua Zhai, Xin Chen, Guixin Zhang, Sizhou Feng, Mingzhe Han, Erlie Jiang

Blood (2022) 140 (Supplement 1): 7714–7715.

https://doi.org/10.1182/blood-2022-165085

Published: 2022

Journal Articles

Oral Posaconazole or Intravenous-Oral Itraconazole in Preventing Invasive Fungal Diseases for Patients with Acute Leukemia

Li Liu, Xiaolei Pei, Runzhi Ma, Yi He, Rongli Zhang, MD, Jialin Wei, Qiaoling Ma, Weihua Zhai, MD, Erlie Jiang, Aiming Pang, MD PhD, Donglin Yang, Sizhou Feng, MDPhD, Ming-Zhe Han, MD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-141508

Published: 2020

Journal Articles

Prognostic Prediction Clinical-Molecular Model for Allogeneic Transplant Outcomes in Patients with Myelodysplastic Syndrome

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-140676

Published: 2020

NARROW

Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for ASCT in Patients with Low- or Intermediate-Risk AML

Allogeneic Peripheral Blood Stem Cell Transplantation for Myeloid Sarcoma: A Single-Center Experience

Humanized Anti-CD25 Monoclonal Antibody for Graft-Versus-Host Disease Prophylaxis in Older Patients Receiving Haploidentical Hematopoietic Stem Cell Transplantation

The Efficacy and Safety of the Addition of Mitoxantrone Hydrochloride Liposome in Conditioning Regimen for High-Risk Acute Myeloid Leukemia: The Short-TERM Analysis

The Comparison between Chimeric Mouse-Human and Humanized Anti-CD25 Monoclonal Antibody for Steroid-Refractory Acute Graft-Versus-Host Disease

Outcomes of Hematopoietic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for B-Cell Acute Lymphoblastic Leukemia without VOD/SOS

The Modified Melphalan-Cladribine-Busulfan-Cyclophosphamide (MCBC) Conditioning Regimen Improved Relapse-Free Survival after Allo-HSCT in Refractory/Relapsed AML

Venetoclax Plus Azacitidine Versus Azacitidine Alone As Post-Transplant Maintenance Treatment in High-Risk AML and MDS

A Modified Busulfan/Cyclophosphamide Preconditioning Regimen Incorporating Selinexor for Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hematologic Malignancies

Ceftazidime-Avibactam in the Treatment of Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacteria in Hematological Patients: Experience in a Single Center

The Efficacy and Safety of the Third Generation TKI Olverembatinib in Adult Ph+ Acute Lymphoblastic Leukemia with Relapsed Disease or Persistent MRD Bridging to Allo-HSCT: A Case Series from a Single Center

Efficacy and Safety of Olverembatinib-Based Therapies in Patients with Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia

The Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for Autologous-HSCT in Low-Risk and Intermediate-Risk AML Patients

Inotuzumab Ozogamicin in Lymphoid B Cell Malignancy：a Single Center Analysis in the Real World

A Real-World Efficacy of Letermovir Primary Prophylaxis for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation in China: A Single-Center Retrospective Analysis

The Efficacy and Safety of Modified Melphalan and Busulfan-Based Conditioning Regimen for Allogeneic-HSCT in Refractory/Relapsed or Persistent MRD Positive AML Patients

Combination of Cytogenetic Classification and MRD Status Correlates with Outcomes of Autologous Versus Allogeneic Stem Cell Transplantation in Adults with B Cell-Acute Lymphoblastic Leukemia in First Remission

Oral Posaconazole or Intravenous-Oral Itraconazole in Preventing Invasive Fungal Diseases for Patients with Acute Leukemia

Prognostic Prediction Clinical-Molecular Model for Allogeneic Transplant Outcomes in Patients with Myelodysplastic Syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only